Global approach to cardiovascular risk in chronic kidney disease: Reality and opportunities for intervention (Q58949564)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16395261%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

title

Global approach to cardiovascular risk in chronic kidney disease: reality and opportunities for intervention (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16395261%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference

chronic renal insufficiency

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16395261%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Paolo Chiodini

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16395261%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Carmine Zoccali

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16395261%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Pietro Castellino

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16395261%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

7

M Strippoli

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16395261%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

author name string

L De Nicola

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16395261%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

C Donadio

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16395261%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

F Casino

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16395261%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

M Giannattasio

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16395261%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

F Petrarulo

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16395261%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

M Virgilio

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16395261%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

E Laraia

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16395261%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

B R Di Iorio

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16395261%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

V Savica

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16395261%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

G Conte

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16395261%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

TArget Blood Pressure LEvels in Chronic Kidney Disease (TABLE in CKD) Study Group

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16395261%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

language of work or name

English

0 references

publication date

1 February 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16395261%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16395261%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

volume

69

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16395261%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16395261%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

page(s)

538-545

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16395261%20AND%20SRC:MED&resulttype=core&format=json

Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Preventi

15 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000085

7 January 2021

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000085

7 January 2021

Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000085

7 January 2021

The burden of kidney disease: improving global outcomes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000085

7 January 2021

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000085

7 January 2021

2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000085

7 January 2021

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000085

7 January 2021

Randomized trials or observational tribulations?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000085

7 January 2021

Epidemiological evaluation of known and suspected cardiovascular risk factors in chronic renal impairment.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000085

7 January 2021

Cardiac risk factors and the use of cardioprotective medications in patients with chronic renal insufficiency

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000085

7 January 2021

Patterns of medication use in the RRI-CKD study: focus on medications with cardiovascular effects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000085

7 January 2021

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000085

7 January 2021

Control of hypertension in adults with chronic kidney disease in the United States

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000085

7 January 2021

Relationship between C-reactive protein, albumin, and cardiovascular disease in patients with chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000085

7 January 2021

Prevalence of acidosis and inflammation and their association with low serum albumin in chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000085

7 January 2021

Management of hypertension in patients with CKD: differences between primary and tertiary care settings.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000085

7 January 2021

Unreferred chronic kidney disease: a longitudinal study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000085

7 January 2021

Achievement of target blood pressure levels in chronic kidney disease: a salty question?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000085

7 January 2021

Role of excess volume in the pathophysiology of hypertension in chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000085

7 January 2021

https://api.crossref.org/works/10.1038%2FSJ.KI.5000085

1 reference

7 January 2021

Combination therapy with ACE inhibitors and angiotensin II receptor blockers to halt progression of chronic renal disease: pathophysiology and indications

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000085

7 January 2021

Treating anemia early in renal failure patients slows the decline of renal function: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000085

7 January 2021

Cardiovascular effect of normalizing the hematocrit level during erythropoietin therapy in predialysis patients with chronic renal failure.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000085

7 January 2021

Anemia treatment in the pre-ESRD period and associated mortality in elderly patients.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000085

7 January 2021

Predialysis Survey on Anemia Management: patient referral

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000085

7 January 2021

Effects of anemia and left ventricular hypertrophy on cardiovascular disease in patients with chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000085

7 January 2021

Effect of pravastatin on loss of renal function in people with moderate chronic renal insufficiency and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000085

7 January 2021

Effect of pravastatin on cardiovascular events in people with chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000085

7 January 2021

Renal insufficiency and worsened prognosis with STEMI: a call for action

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000085

7 January 2021

Benefits of aspirin and beta-blockade after myocardial infarction in patients with chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000085

7 January 2021

Survival after coronary revascularization among patients with kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000085

7 January 2021

Renal replacement therapy for diabetic end-stage renal disease: data from 10 registries in Europe (1991-2000).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000085

7 January 2021

Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000085

7 January 2021

Traditional and nontraditional risk factors predict coronary heart disease in chronic kidney disease: results from the atherosclerosis risk in communities study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000085

7 January 2021

Cardiovascular mortality risk in chronic kidney disease: comparison of traditional and novel risk factors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000085

7 January 2021

Statistical methods for assessing agreement between two methods of clinical measurement

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000085

7 January 2021

Goodness-of-fit tests for ordinal response regression models

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000085

7 January 2021

Identifiers

DOI

10.1038/SJ.KI.5000085

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16395261%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference